Yüklüyor......

Immunotherapy in Gynecologic Cancers: Are We There Yet?

Immune-targeted therapies have demonstrated durable responses in many tumor types with limited treatment options and poor overall prognosis. This has led to enthusiasm for expanding such therapies to other tumor types including gynecologic malignancies. The use of immunotherapy in gynecologic malign...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Curr Treat Options Oncol
Asıl Yazarlar: Pakish, Janelle B., Jazaeri, Amir A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5936621/
https://ncbi.nlm.nih.gov/pubmed/28840453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11864-017-0504-y
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!